Skip to main content
. 2026 Mar 23;16(6):953. doi: 10.3390/diagnostics16060953
MPAL Mixed-Phenotype Acute Leukemia
BAL Acute Biphenotypic Leukemia
EGIL European Group for the Immunological Characterization of Leukemias
ALL Acute Lymphoblastic Leukemia
AML Acute Myeloid Leukemia
Allo-HSCT Allogeneic Hematopoietic Stem Cell Transplantation
WHO World Health Organization
ALAL Acute Leukemias of Ambiguous Lineage
AUL Acute Undifferentiated Leukemia
MS Myeloid Sarcoma
NOS Not Otherwise Specified
IVF In Vitro Fertilization
CR Complete Remission
EMD Extramedullary Disease
P-gp P-Glycoprotein
MDR Multidrug Resistance
MDS Myelodysplastic Syndrome
MPN Myeloproliferative Neoplasm
ALT Alanine Aminotransferase
AST Aspartate Aminotransferase
GGT Gamma-Glutamyl Transferase
TTE Transthoracic Echocardiography
LVEF Left Ventricular Ejection Fraction
IVS Interventricular Septum
PWT Posterior Wall Thickness
RV Right Ventricle
CT Computed Tomography
T-LBL T-cell Lymphoblastic Lymphoma
SaO2 Oxygen Saturation
IHC Immunohistochemistry
PAS Periodic Acid–Schiff
MPO Myeloperoxidase
MGG May–Grünwald–Giemsa
TdT Terminal Deoxynucleotidyl Transferase
HD-AraC High-Dose Cytarabine
MUD Matched Unrelated Donor
ATG Anti-Thymocyte Globulin
GVHD Graft-Versus-Host Disease
CBC Complete Blood Count
WBC White Blood Cell
MRI Magnetic Resonance Imaging
AVN Avascular Necrosis
OS Overall Survival
PFS Progression-Free Survival
EHA European Hematology Association
CMML Chronic Myelomonocytic Leukemia
EBMT European Society for Blood and Marrow Transplantation
CML Chronic Myeloid Leukemia
GvL Graft-Versus-Leukemia
APL Acute Promyelocytic Leukemia
DLBCL Diffuse Large B-Cell Lymphoma
EFS Event-Free Survival